Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

ethyl 2-cyano-2-(hydroxyimino)acetate

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Ethyl 2-cyano-2-(4-nitrophenylsulfonyloxyimino)acetate (4-NBsOXY) mediated Lossen rearrangement and its application for the… Expand
2014
2014
A diisopropylcarbodiimide/Oxyma (ethyl 2-cyano-2-(hydroxyimino)acetate) coupling cocktail was successfully incorporated into the… Expand
2013
2013
OxymaPure (ethyl 2-cyano-2-(hydroxyimino)acetate) was tested as an additive for use in the carbodiimide (DIC) approach for the… Expand
  • table 1
  • table 2
2012
2012
The presence of low pKa N‐hydroxylamines is beneficial in peptide chemistry as they reduce some base‐mediated side reactions… Expand
2010
2010
A new family of sulfonate ester-type coupling reagents is described which differs in its leaving group. The sulfonate ester… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Highly Cited
2010
Highly Cited
2010
COMU is a third generation of uronium‐type coupling reagent based on ethyl 2‐cyano‐2‐(hydroxyimino)acetate (Oxyma) as well as a… Expand
2010
2010
Recent studies described the great impact of a non-benzotriazolic family of coupling reagents based on ethyl 2-cyano-2… Expand
  • figure 1
  • figure 4
  • figure 3
  • figure 2
  • table 2
2010
2010
A new class of 1,3,5-triazinyloxyimino derivatives were prepared, characterized and tested for reactivity in solution peptide… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
Highly Cited
2009
Highly Cited
2009
Oxyma [ethyl 2-cyano-2-(hydroxyimino)acetate] has been tested as an additive for use in the carbodiimide approach for formation… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 6
Highly Cited
2009
Highly Cited
2009
We describe a new family of uronium-type coupling reagents that differ in their iminium moieties and leaving groups. The presence… Expand
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • table 2